Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

White hairs often regrow in alopecia areata patches.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

The guidelines offer updated treatment recommendations for alopecia areata in Korea using topical and device-based methods.

Hair loss treatment caused more hair loss in a man.

Cancer treatments often cause skin, nail, and hair problems.

Mesotherapy can cause bruises, swelling, and serious complications, so awareness and careful practice are important.

Cognitive-behavioral therapy with habit reversal training is the most effective treatment for trichotillomania.

A machine learning model can predict alopecia areata early using specific gene markers.

ChatGPT-5 can pass the endocrinology exam but isn't fully reliable for clinical decisions yet.

Vitamin D might help treat alopecia areata.

Most patients with Lichen planopilaris improved with acitretin, but treatments often didn't work well; preventing infection in skin surgery is important, and bupivacaine might be a better anesthetic.

Pregnancy can cause skin changes and issues that need careful management.

The new Hairless R/J mice model improves imaging for tumor monitoring and cancer therapy evaluation.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

The treatment showed limited success in repigmenting hair for vitiligo-associated leukotrichia.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

Injectable platelet-rich fibrin therapy improved hair and scalp conditions in women with excessive hair loss.

Catechins-rich tea extract may help reduce hair loss and promote hair growth.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Gut microbiota changes might play a role in alopecia areata, and microbiome-targeted treatments show promise.

Topical immunotherapy can help with severe hair loss, but results vary and need personalized, long-term treatment.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.